TIP regimen: Difference between revisions

	WikiDoc Resources for TIP regimen
Articles
Most recent articles on TIP regimen Most cited articles on TIP regimen Review articles on TIP regimen Articles on TIP regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on TIP regimen Images of TIP regimen Photos of TIP regimen Podcasts & MP3s on TIP regimen Videos on TIP regimen
Evidence Based Medicine
Cochrane Collaboration on TIP regimen Bandolier on TIP regimen TRIP on TIP regimen
Clinical Trials
Ongoing Trials on TIP regimen at Clinical Trials.gov Trial results on TIP regimen Clinical Trials on TIP regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on TIP regimen NICE Guidance on TIP regimen NHS PRODIGY Guidance FDA on TIP regimen CDC on TIP regimen
Books
Books on TIP regimen
News
TIP regimen in the news Be alerted to news on TIP regimen News trends on TIP regimen
Commentary
Blogs on TIP regimen
Definitions
Definitions of TIP regimen
Patient Resources / Community
Patient resources on TIP regimen Discussion groups on TIP regimen Patient Handouts on TIP regimen Directions to Hospitals Treating TIP regimen Risk calculators and risk factors for TIP regimen
Healthcare Provider Resources
Symptoms of TIP regimen Causes & Risk Factors for TIP regimen Diagnostic studies for TIP regimen Treatment of TIP regimen
Continuing Medical Education (CME)
CME Programs on TIP regimen
International
TIP regimen en Espanol TIP regimen en Francais
Business
TIP regimen in the Marketplace Patents on TIP regimen
Experimental / Informatics
List of terms related to TIP regimen

VisualWikitext

Latest revision as of 15:08, 30 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Taxol-Ifosfamide-Platinol Regimen; TIP Regimen

Overview

TIP regimen refers to a regimen consisting of paclitaxel, ifosfamide, mesna and cisplatin used for the treatment of advanced-stage testicular cancer^[1]; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer.^[2]

Regimen

TTaxol (paclitaxel)

IIfosfamide

PPlatinol (cisplatin)

Indications

Advanced-stage testicular cancer^[1], Squamous cell head and neck cancer^[2]^[3]

References

↑ ^1.0 ^1.1 Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J; et al. (2005). "Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors". J Clin Oncol. 23 (27): 6549–55. doi:10.1200/JCO.2005.19.638. PMID 16170162.
↑ ^2.0 ^2.1 Shin DM (2000). "Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck". Semin Oncol. 27 (1 Suppl 1): 36–40. PMID 10697043.
↑ "NCI Thesaurus".

[pmid16170162-1] 1.0 ^1.1 Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J; et al. (2005). "Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors". J Clin Oncol. 23 (27): 6549–55. doi:10.1200/JCO.2005.19.638. PMID 16170162.

[pmid10697043-2] 2.0 ^2.1 Shin DM (2000). "Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck". Semin Oncol. 27 (1 Suppl 1): 36–40. PMID 10697043.

[3] "NCI Thesaurus".

[1]

[2]

[3]

@@ Line 6: / Line 6: @@
 ==Overview==
-{{PAGENAME}} refers to  a regimen consisting of [[paclitaxel]], [[ifosfamide]], [[mesna]] and [[cisplatin]] used for the treatment of advanced-stage testicular cancer; also used for the treatment of unresectable and recurrent [[head and neck cancer|squamous cell head and neck cancer]].<ref name="pmid16926060">{{cite journal| author=Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F et al.| title=Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. | journal=Lung Cancer | year= 2006 | volume= 54 | issue= 1 | pages= 63-7 | pmid=16926060 | doi=10.1016/j.lungcan.2006.05.027 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16926060 }} </ref>
+{{PAGENAME}} refers to  a regimen consisting of [[paclitaxel]], [[ifosfamide]], [[mesna]] and [[cisplatin]] used for the treatment of advanced-stage [[testicular cancer]]<ref name="pmid16170162">{{cite journal| author=Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J et al.| title=Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 27 | pages= 6549-55 | pmid=16170162 | doi=10.1200/JCO.2005.19.638 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16170162  }} </ref>; also used for the treatment of unresectable and recurrent [[head and neck cancer|squamous cell head and neck cancer]].<ref name="pmid10697043">{{cite journal| author=Shin DM| title=Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. | journal=Semin Oncol | year= 2000 | volume= 27 | issue= 1 Suppl 1 | pages= 36-40 | pmid=10697043 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10697043  }} </ref>
 ==Regimen==
@@ Line 16: / Line 16: @@
 ==Indications==
-*[[head and neck cancer|squamous cell head and neck cancer]]<ref name="pmid16926060">{{cite journal| author=Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F et al.| title=Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. | journal=Lung Cancer | year= 2006 | volume= 54 | issue= 1 | pages= 63-7 | pmid=16926060 | doi=10.1016/j.lungcan.2006.05.027 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16926060 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63490&ns=NCI_Thesaurus}}</ref>
+*[[testicular cancer|Advanced-stage testicular cancer]]<ref name="pmid16170162">{{cite journal| author=Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J et al.| title=Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 27 | pages= 6549-55 | pmid=16170162 | doi=10.1200/JCO.2005.19.638 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16170162  }} </ref>, [[head and neck cancer|Squamous cell head and neck cancer]]<ref name="pmid10697043">{{cite journal| author=Shin DM| title=Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. | journal=Semin Oncol | year= 2000 | volume= 27 | issue= 1 Suppl 1 | pages= 36-40 | pmid=10697043 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10697043  }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63490&ns=NCI_Thesaurus}}</ref>
 ==References==